This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08572/identifier/chemspider/
n12http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB08572/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB08572/identifier/pubchem-compound/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08572/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n14http://linked.opendata.cz/resource/drugbank/drug/DB08572/identifier/drugbank/
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08572
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n7:DB08572 n12:DB08572
dcterms:title
4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE
adms:identifier
n9:99445043 n10:ST8 n11:5289411 n13:4451389 n14:DB08572
n4:IUPAC-Name
n5:271B6523-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B6529-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B6528-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B6525-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B6526-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B6527-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B6521-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B6522-363D-11E5-9242-09173F13E4C5 n5:271B651F-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B6520-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B652F-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B6530-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B652A-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B652B-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B652D-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B652C-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B652E-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B6535-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B6537-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B6538-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B6534-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B6533-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B6536-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B6524-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B6531-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B6532-363D-11E5-9242-09173F13E4C5